SCHEMBL16620099

SCHEMBL16620099

CN(Cc1cncc(C(=O)O)c1)C(=O)c1ccc(CC2CCC(C(O[Si](C)(C)C(C)(C)C)c3ccc(Cl)nc3)N2C(=O)OC(C)(C)C)cc1

nearest known ligand 0.32

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
CETP P11597 4/20 0.32
ADRB1 P08588 1/20 0.30
ADRB3 P13945 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16629853 1.00 CETP (0.32) CETPADRB1ADRB3
SCHEMBL16629854 0.94 P2RX3 (0.31) CETP
SCHEMBL16630653 0.93 CNR1 (0.33) CETP
SCHEMBL16630233 0.92 CETP (0.32) CETP
SCHEMBL16629822 0.92 CETP (0.31) CETP
SCHEMBL16629911 0.92 CETP (0.33) CETP
SCHEMBL18017452 0.91 AGTR2 (0.33) CETP
SCHEMBL17986551 0.91 LIMK2 (0.33) CETP
SCHEMBL16629818 0.91 GPR119 (0.37)
SCHEMBL16629791 0.90 ACACB (0.35) CETP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3052099-A1 NOVEL PYRROLIDINE DERIVED BETA 3 ADRENERGIC RECEPTOR AGONISTS Merck Sharp & Dohme Corp. (US) 2016-08-10 EP disclosed
WO-2015050798-A1 NOVEL PYRROLIDINE DERIVED BETA 3 ADRENERGIC RECEPTOR AGONISTS MERCK SHARP & DOHME CORP. (US) 2015-04-09 WO disclosed